Ophthalmology · Danbury, CT
NPI
1053802454
Since 2018
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
57 North St Ste 415
Danbury, CT, 06810
Phone (203) 628-4995
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
171 services
Medicare patients, 2024
85
Average age 75
Drug cost, 2024
$1.5M
10,260 prescriptions
Company payments, 2025
$1,792
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary W Tam was code 99214 (office e&m - established), 43 times for 41 patients. In total Mary W Tam billed 171 services in 23 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 43 | 41 | $96.79 | $4,162 |
| 92083 Vision, Hearing, and Speech Services | Office | 21 | 19 | $25.15 | $528 |
| 92133 Computerized Ophthalmic Imaging | Office | 17 | 17 | $27.06 | $460 |
| 99213 Office E&M - Established | Office | 15 | 13 | $62.23 | $934 |
By year: 2022 $9,932 for 103 services; 2023 $10K for 136 services; 2024 $14K for 171 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mary W Tam prescribed most often to Medicare patients was Latanoprost, with 2,113 prescriptions and refills. In total Mary W Tam wrote 10,260 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 2,113 | 3,181 | 697 | $17K |
| Lumigan Bimatoprost | 1,414 | 1,925 | 445 | $499K |
| Prednisolone Acetate Generic | 1,005 | 1,227 | 675 | $38K |
| Brimonidine Tartrate Generic | 865 | 1,281 | 305 | $42K |
| Moxifloxacin Moxifloxacin Hcl | 691 | 691 | 582 | $23K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 682 | 1,246 | 262 | $8,785 |
| Combigan Brimonidine Tartrate/Timolol | 416 | 618 | 130 | $147K |
| Dorzolamide Hcl Generic | 356 | 601 | 149 | $6,571 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 282 | 339 | 96 | $116K |
| Rhopressa Netarsudil Mesylate | 275 | 335 | 111 | $106K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 244 | 353 | 91 | $29K |
| Timolol Maleate Generic | 242 | 410 | 98 | $7,548 |
| Ilevro Nepafenac | 230 | 330 | 210 | $84K |
| Restasis Cyclosporine | 165 | 206 | 71 | $107K |
| Alphagan P Brimonidine Tartrate | 156 | 247 | 63 | $60K |
Brand drugs: 5,890 claims; generic drugs: 4,370 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary W Tam $1,792 ($1,792 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $606.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $606 |
| Alcon Vision LLC ALC | 5 | $330 |
| Amgen Inc. AMGN | 7 | $218 |
| Tarsus Pharmaceuticals, Inc. TARS | 3 | $146 |
| Organon LLC OGN | 1 | $143 |
| Mallinckrodt Hospital Products Inc. | 4 | $134 |
| Dompe US, Inc. | 2 | $39.68 |
| Astellas Pharma US Inc 4503.T | 1 | $29.71 |
| Sight Sciences, Inc. SGHT | 1 | $26.67 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $26.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.